Vident Investment Advisory’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-105,398
| Closed | -$77K | – | 1368 |
|
|
2022
Q3 | $77K | Buy |
105,398
+13,978
| +15% | +$10.2K | ﹤0.01% | 1078 |
|
|
2022
Q2 | $104K | Buy |
91,420
+7,443
| +9% | +$8.47K | ﹤0.01% | 1190 |
|
|
2022
Q1 | $172K | Buy |
83,977
+33,418
| +66% | +$68.4K | ﹤0.01% | 1205 |
|
|
2021
Q4 | $146K | Buy |
50,559
+1,958
| +4% | +$5.65K | ﹤0.01% | 1168 |
|
|
2021
Q3 | $206K | Buy |
+48,601
| New | +$206K | 0.01% | 1083 |
|